EFFECT OF METHANOL YEAST EXTRACT ON 3T3 FIBROBLAST CELLS 401 (11) E. Król, Z. Krejpcio, H. Byks, P. Bogdański, and D. Pupek-Musialik, Effects of chromium brewer’s yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients, Biol. Trace. Elem. Res., 143, 726–737 (2011). (12) S. Rahar, G. Swami, N. Nagpal, M. A. Nagpal, and G. S. Sing, Preparation, characterization, and bio- logical properties of β-glucans. J. Adv. Pharm. Technol. Res., 2, 94–103 (2011). (13) I. M. Thompson, C. R. Spence, D. L. Lamm, and N. R. DiLuzio, Immunochemotherapy of bladder carcinoma with glucan and cyclophosphamide, Am. J. Med. Sci., 294, 294–300 (1987). (14) D. K. Meena, P. Das, S. Kumar, S. C. Mandal, A. K. Prusty, S. K. Singh, M. S. Akhtar, B. K. Behera, K. Kumar, A. K. Pal, and S. C, Mukherjee. Beta-glucan: An ideal immunostimulant in aquaculture (a review), Fish. Physiol. Biochem., 39, 431–457 (2013). (15) F. Zulli, F. Suter, H. Biltz, and H. P. Nissen, Improving skin function with CM-glucan, a biological response modifi er from yeast, Int. J. Cosmet. Sci., 20, 79–86 (1998). (16) M. Dillemans, L. Van Nedervelde, and A. Debourg, Characterization of a novel yeast factor increasing yeast brewing performances, Proc. Congr. Eur. Brew. Conv., 27, 711–718 (1999). (17) M. Dillemans, L. Van Nedervelde, and A. Debourg, An approach to the mode of action of a novel yeast factor increasing yeast brewing performance, J. Am. Soc. Brew. Chem., 59, 101–106 (2001). (18) D. P. A. Cortes, A. F. E. Domingo, A. C. Daquinag, and C. T. Hedreyda, A possible role of peptides in the growth enhancement of an industrial strain of Saccharomyces sp, Science Diliman, 17, 1 (2005). (19) M. Dillemans, L. Van Nedervelde, and A. Debourg, Novel specifi c method for the obtention of a fer- mentation activator isolated from yeast, Proceedings of the 30th EBC Congress (2005). (20) E. Parrella, and V. D. Longo, The chronological life span of Saccharomyces cerevisiae to study mitochon- drial dysfunction and disease, Methods, 46, 256–262 (2008). (21) M. R. Szabo, C. Iditoiu, D. Chambre, and A. X. Lupea, Improved DPPH determination for antioxidant activity spectrometric assay, Chemical Papers, 61, 214–216 (2007). (22) M. Dillemans, T. Appelboom, and L. Van Nedervelde, Yeast as a model system for identifi cation of metabolic targets of a ‘glucosamine complex’ used as a therapeutic agent of osteoarthritis, Biomed. Phar- macother., 62, 645-50 (2008). (23) D. Gallo, F. Jacquemotte, A. Cleeren, I. Laïos, S. Hadiy, M. G. Rowlands, O. Caille, D. Nonclercq, G. Laurent, Y. Jacquot, and G. Leclercq, Calmodulin-independent, agonistic properties of a peptide containing the calmodulin binding site of estrogen receptor alpha, Mol. Cell. Endocrinol., 268, 37–49 (2007). (24) M. Kampa, V. Pelekanou, D. Gallo, G. Notas, M. Troullinaki, I. Pediaditakis, I. Charalampopoulos, Y. Jacquot, G. Leclercq, and E. Castanas, ERα17p, an ERα P295 -T311 fragment, modifi es the migration of breast cancer cells, through actin cytoskeleton rearrangements, J. Cell Biochem., 112, 3786–3796 (2011).